Clinical Trial Update: Factor VIIa in Acute Intracerebral Haemorrhage [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating recombinant activated Factor VII (NovoSeven RT) for acute intracerebral hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• NovoSeven RT (Recombinant activated factor VII)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Acquired Bleeding Disorder, Intracerebral Haemorrhage | Phase 2 | Status: COMPLETED